EPO and chronic kidney disease: Moreover, we showed that renal GATA-2 and its target genes are increased in CKD, which might explain the reduced renal expression of HIF-2α and EPO. In addition, since TNF-α levels are increased by CKD, this might be the link between CKD and increased GATA-2 activity.